Smart and Stimuli Responsive Drug Delivery Systems: A Horizon in Formulation Development

Smart and stimuli-responsive drug delivery systems (SRDDS) represent an innovative approach in pharmaceutical formulation development by enabling targeted and controlled drug release in response to specific internal or external stimuli. These systems employ advanced materials such as smart polymers, hydrogels, lipid-based carriers, and nanomaterials to enhance therapeutic efficacy, reduce systemic toxicity, and improve patient compliance. SRDDS respond to endogenous stimuli like pH, enzymes, temperature, and redox conditions, as well as exogenous triggers including light, ultrasound, and magnetic fields for precise drug delivery. Their mechanism involves physicochemical changes such as polymer swelling, bond cleavage, and sol-gel transition. These systems are widely applicable in oncology, neurology, ophthalmology, and regenerative medicine. Recent advances in nanotechnology, artificial intelligence, and computational modeling have accelerated the optimization of SRDDS. Despite challenges related to stability, scalability, and regulatory approval, SRDDS hold significant promise as future platforms for precision, adaptive, and patient-centered therapeutics.